TNKase is administered as a single intravenous bolus over 5 seconds. The Food and Drug Administration (FDA) has approved TNKase ® (tenecteplase) for the treatment of acute ischemic stroke (AIS) in ...
New York, USA, March 02, 2026 (GLOBE NEWSWIRE) -- Acute Ischemic Stroke Market Poised for Expansion During the Forecast Period (2026–2036) as Innovative Treatment Modalities Gain Momentum | ...
A clinical decision support tool that uses artificial intelligence (AI) to analyze scans after a stroke alongside treatment ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The study examined 352 individuals with stroke ...
A clotbusting drug commonly used to treat ischemic stroke interacts negatively with a promising anti-inflammatory treatment (anakinra), underscoring the need to test new stroke therapies alongside ...
Recent research has revealed compelling evidence supporting tenecteplase as a more effective treatment for ischemic strokes compared to traditional alteplase therapy. This discovery could mark a major ...
For acute ischemic stroke within 48 hours of onset, the novel sublingual combination of edaravone (Radicava) with dexborneol appeared to dramatically improve functional outcomes in the phase III TASTE ...
Key points A 68-year-old woman presented to the emergency department of a rural hospital in southern Alberta 1 hour after ...
Cerebrolysin, a porcine brain-derived neuropeptide preparation, has emerged as a promising intervention for ischaemic stroke owing to its neuroprotective and neurotrophic properties. Its multifaceted ...
PARIS--(BUSINESS WIRE)--Sensome, the pioneer of microsensing technology for instant intra-operative tissue analysis, today announced positive results from its first-in-human CLOT OUT clinical trial ...
Share on Pinterest Adding blood thinners to clot-busting medication after a stroke does not appear to improve the outcomes, according to a new study. credit: szjphoto/Getty Images. About 15 million ...